BioCentury | Jan 9, 2006
Finance

Germany's crossover angel

...E4.5M ($5.3M) seed round in 2000 and received a further E15.5M ($18.4M) in 2001-2003 from New Market Venture...
...closed in March 2004, at which time the company reorganized to become a subsidiary of New Market Venture...
BioCentury | May 24, 2004
Finance

Top European B rounds

...Science Partners; HB BioVentures; Sofinnova Partners; GIMV; Mara Ventures Heidelberg $30.6 3/9/04 Infectious; cancer Germany New Market Venture...
BioCentury | May 17, 2004
Finance

U.S. investment in Europe

...Global Life Science Ventures; HBM BioVentures; Sofinnova Partners; GIMV; Mara Ventures Heidelberg Pharma Germany $30.6 New Market Venture BC...
Items per page:
1 - 3 of 3
BioCentury | Jan 9, 2006
Finance

Germany's crossover angel

...E4.5M ($5.3M) seed round in 2000 and received a further E15.5M ($18.4M) in 2001-2003 from New Market Venture...
...closed in March 2004, at which time the company reorganized to become a subsidiary of New Market Venture...
BioCentury | May 24, 2004
Finance

Top European B rounds

...Science Partners; HB BioVentures; Sofinnova Partners; GIMV; Mara Ventures Heidelberg $30.6 3/9/04 Infectious; cancer Germany New Market Venture...
BioCentury | May 17, 2004
Finance

U.S. investment in Europe

...Global Life Science Ventures; HBM BioVentures; Sofinnova Partners; GIMV; Mara Ventures Heidelberg Pharma Germany $30.6 New Market Venture BC...
Items per page:
1 - 3 of 3